Health News

Amgen (Nasdaq: AMGN) announced that results from the PRIME ‘203′ and ‘181′ pivotal Phase 3 trials evaluating Vectibix® (panitumumab) in combination with chemotherapy (FOLFOX or FOLFIRI) as a first and second-line treatment for metastatic colorectal cancer (mCRC), respectively, were published online in the Journal of Clinical Oncology…

Read more

Filed under: Pharmacy News
Tags: cancer, Oncology, Online, Pharmacy

Related posts

• When To Administer Food And Drugs Together (0)
  A regulatory bias against taking oral anti-cancer medications with food places many patients at increased risk for an overdose and forces them to "flush costly medicines down the toilet," argues Mark Ratain, MD, an authority on cancer-drug dosing. In a commentary published early online Sept. 19 in the Journal of Clinical Oncology, Ratain, the Leon [...]
  
  
• Sunitinib shows promise for advanced kidney cancer patients with poor prognosis (0)
  Sunitinib prolongs progression-free and overall survival, and is safe and well tolerated in advanced kidney cancer (metastatic renal cell carcinoma) patients with a poor prognosis such as the elderly and those whose cancer has spread to the brain, finds an Article published Online First (www.thelancet.com) and in the August edition of The Lancet Oncology. Read more [tags] [...]
  
  
• Scientists study a botanical formula that kills aggressive prostate cancer tumors (0)
  Scientists at Indiana University, Methodist Research Institute study a botanical formula that kills aggressive prostate cancer tumors. Their findings, based on experiments in mice using a human prostate cancer tumor model, appear online in The International Journal of Oncology. Read more [tags] Pharmacy News [/tags]
  
  
• Researchers find genetic variants that cause arthritis in breast cancer patients taking aromatase inhibitors (0)
  Mayo Clinic researchers and their international colleagues have discovered genetic variants that lead to severe arthritis for a subset of women when taking aromatase inhibitors to treat their breast cancer. This serious side effect is so painful that many women halt their lifesaving medication. The findings appear today in the online issue of Journal of [...]
  
  
• Radioactive tracing agent can identify tumor-draining sentinel nodes in breast cancer, melanoma patients (0)
  Researchers say a new kind of tracing agent is more accurate than current methods in helping identify tumor-draining sentinel lymph nodes in breast cancer and melanoma patients. That's the finding in a new study that appears in the online version of the Annals of Surgical Oncology. Read more [tags] Pharmacy News [/tags]